Related Experiment Video
Updated: Jun 18, 2026

08:19
Hollow Microneedle-based Sensor for Multiplexed Transdermal Electrochemical Sensing
Published on: June 1, 2012
14.5K
Modeling of Microneedle Arrays in Transdermal Drug Delivery Applications
Francisco Henriquez1, Diego Celentano2, Marcela Vega3
1Facultad de Ingeniería, Departamento de Tecnologías Industriales, Universidad de Talca, Camino Los Niches Km 1, Curicó 3340000, Chile.
Pharmaceutics
|February 25, 2023
Summary
Computational fluid dynamics simulations show hollow microneedle arrays (MNAs) can improve analgesic drug delivery. Vertical flow through MNAs offers better fluid distribution and skin infiltration for enhanced transdermal drug administration.
Area of Science:
- Biomedical Engineering
- Computational Science
- Pharmacology
Background:
- Computational tools accelerate medical and engineering technology development.
- Hollow microneedle arrays (MNAs) are explored for drug administration.
Purpose of the Study:
- To evaluate two hollow microneedle array designs for analgesic drug delivery using CFD simulations.
- To model drug behavior within the MNA and its entry into a simulated biological medium.
Main Methods:
- Computational Fluid Dynamics (CFD) simulations were performed in three stages.
- Simulations analyzed lidocaine flow through MNAs and into a porous aqueous medium.
- Key parameters included inlet velocity (0.05 m/s), pressure (2000 Pa), laminar flow, and inlet resistance (400 Pa).
Main Results:
- Vertical flow through MNAs demonstrated superior fluid distribution compared to other designs.
- Favorable infiltration behavior was observed, indicating efficient drug delivery.
- The simulation successfully modeled the interaction between MNA outflow and the biological medium.
Conclusions:
- Hollow microneedle arrays show promise for effective transdermal analgesic delivery.
- CFD simulations are valuable for optimizing MNA design and drug administration protocols.
- Vertical flow configurations enhance drug distribution and skin penetration for improved therapeutic outcomes.

